A Phase 2 Study of CAL101 in Patients With Idiopathic Pulmonary Fibrosis

Clinical trial NCT06736990 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06736990
Sponsor: Calluna Pharma AS
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Idiopathic Pulmonary Fibrosis

Start date: 2025-06-20
Primary completion: 2026-11-01
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.